berberine has been researched along with olanzapine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Sen, S; Sinha, N | 1 |
Lewis, DA; Siegel, BI; Verrico, CD; Volk, DW | 1 |
Davies, GE; Davies, PS; Droke, EA; Ehli, EA; Hu, Y; Nowotny, D; Soundy, TJ; Young, AJ | 1 |
Deng, C; Feng, X; Hu, CH; Li, Y; Liu, X; Zhao, X | 1 |
Al-Gareeb, AI; Al-Kuraishy, HM; Al-Naimi, MS; Rasheed, HA | 1 |
Bansal, Y; Bishnoi, M; Kondepudi, KK; Kuhad, A; Medhi, B; Singh, DP; Singh, R; Sodhi, RK | 1 |
Hou, Q; Jiang, H; Li, G; Pu, Z; Sun, Y; Wen, H; Yan, H | 1 |
1 trial(s) available for berberine and olanzapine
Article | Year |
---|---|
Effects of Berberine on Gut Microbiota in Patients with Mild Metabolic Disorders Induced by Olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Berberine; Gastrointestinal Microbiome; Humans; Metabolic Diseases; Olanzapine | 2021 |
6 other study(ies) available for berberine and olanzapine
Article | Year |
---|---|
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Endocannabinoid metabolism in the prefrontal cortex in schizophrenia.
Topics: Adolescent; Adult; Age Factors; Animals; Antipsychotic Agents; Benzodiazepines; Berberine; Calcium Channel Blockers; Endocannabinoids; Female; Gene Expression Regulation; Haloperidol; Humans; Macaca fascicularis; Male; Middle Aged; Monoacylglycerol Lipases; Olanzapine; Prefrontal Cortex; Schizophrenia; Young Adult | 2013 |
Metformin and berberine prevent olanzapine-induced weight gain in rats.
Topics: Adipose Tissue, White; Animals; Antipyretics; Benzodiazepines; Berberine; Eating; Female; Ion Channels; Metformin; Mitochondrial Proteins; Olanzapine; Organ Size; Rats; Rats, Sprague-Dawley; Transcriptome; Uncoupling Protein 1; Weight Gain | 2014 |
Berberine Alleviates Olanzapine-Induced Adipogenesis via the AMPKα-SREBP Pathway in 3T3-L1 Cells.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; AMP-Activated Protein Kinases; Animals; Antipsychotic Agents; Benzodiazepines; Berberine; Cell Differentiation; Cholesterol; Fatty Acid Synthase, Type I; Gene Expression Regulation; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Hypolipidemic Agents; Lipid Metabolism; Mice; Olanzapine; Phosphorylation; PPAR gamma; Receptors, LDL; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Triglycerides | 2016 |
Berberine attenuates olanzapine induced-metabolic syndrome.
Topics: Animals; Berberine; Biomarkers; Insulin Resistance; Male; Metabolic Syndrome; Olanzapine; Prospective Studies; Rats; Rats, Sprague-Dawley; Weight Gain | 2019 |
Berberine attenuated olanzapine-induced metabolic alterations in mice: Targeting transient receptor potential vanilloid type 1 and 3 channels.
Topics: Animals; Antipsychotic Agents; Berberine; Body Temperature; Body Weight; Cytokines; Drinking; Female; Gene Expression Regulation; Ghrelin; Hypothalamus; Leptin; Metabolic Diseases; Metformin; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Neuropeptides; Obesity; Olanzapine; RNA, Messenger; Signal Transduction; Treatment Outcome; TRPV Cation Channels | 2020 |